Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

BOM/538965 stock hub

BOM/538965 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BOM/538965is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.1B

Bombay Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BOM/538965

In the news

Latest news · BOM/538965

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E179.3

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC3.6

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BOM/538965 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

169

Groups with data

Currency

INR

Showing 169 of 169 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	250
Employees Change	65%
Employees Change Percent	35.14
Enterprise value	INR 1.3B
Exchange	Bombay Stock Exchange
Financial currency	INR
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	INR 1.1B
Price	INR 81.51
Price currency	INR
Rev Per Employee	2,049,624x
Sic	2834
Symbol	bom/538965
Website	https://concorddrugs.in

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	0.53%
EV Earnings	222.99x
EV/EBIT	47.01x
EV/EBITDA	31.37x
EV/Sales	2.46x
P/B ratio	3.12x
P/E ratio	179.31x
P/S ratio	2.1x
PE Ratio10 Y	177.66x
PE Ratio3 Y	492.32x
PE Ratio5 Y	281.48x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	5.24%
EBITDA Margin	7.85%
Gross margin	18.32%
Gross Profit	INR 93.9M
Gross Profit Growth	-0.53%
Gross Profit Growth Q	-2.86%
Gross Profit Growth3 Y	-16.31%
Gross Profit Growth5 Y	1.53%
Net Income	INR 5.7M
Net Income Growth Q	-4.32%
Net Income Growth3 Y	-12.69%
Net Income Growth5 Y	-28.55%
Pretax Margin	1.53%
Profit Margin	1.1%
Profit Per Employee	INR 22,632
Roa5y	3.09
Roe5y	4.91
ROIC	3.64
Roic5y	4.38

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	4.01%
Cagr1y	170.71%
Cagr3y	40.31%
Cagr5y	19.79%
EPS Growth Q	-30.44
EPS Growth3 Y	-22.3
EPS Growth5 Y	-33.38
Revenue Growth	1.48x
Revenue Growth Q	57.1x
Revenue Growth3 Y	-2.48x
Revenue Growth5 Y	-1.8x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 3.7M
Debt	INR 191.4M
Debt EBITDA	INR 4.76
Debt Equity	INR 0.56
Equity	INR 344.2M
Interest Coverage	1.47
Net Cash	INR -187.8M
Net Cash By Market Cap	INR -17.48
Net Debt EBITDA	INR 4.67
Net Debt Equity	INR 0.55
Tangible Book Value	INR 344.2M
Tangible Book Value Per Share	INR 33.99
WACC	7.44

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-25.47%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	48.2%
1Y total return	170.53%
200-day SMA	73.02
3Y total return	176.31%
50-day SMA	77.61
50-day SMA vs 200-day SMA	50over200
5Y total return	146.63%
All Time High	92.52
All Time High Change	-11.9%
All Time High Date	2025-11-13
All Time Low	11.68
All Time Low Change	597.86%
All Time Low Date	2020-03-26
ATR	5.17
Beta	0.6
Beta1y	0.65
Beta2y	0.76
Ch YTD	-1.18
High	86.77
High52	92.52
High52 Date	2025-11-13
High52ch	-11.9%
Low	80
Low52	29
Low52 Date	2025-06-23
Low52ch	181.07%
Ma50ch	5.02%
Price vs 200-day SMA	11.63%
RSI	50.81
RSI Monthly	65.35
RSI Weekly	55.12
Sharpe ratio	2.05x
Sortino ratio	4.14
Total Return	-25.47%
Tr YTD	-1.18
Tr1m	14.64%
Tr1w	-3.24%
Tr3m	4.47%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 26.8M
Operating Income Growth	34.55
Operating Income Growth Q	-39.96
Operating Income Growth3 Y	0.89
Operating Income Growth5 Y	7.23
Operating margin	5.24

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4,375,736%
Shares Insiders	66.79%
Shares Out	13,175,000
Shares Qo Q	33.87%
Shares Yo Y	25.47%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	5,773.7x
Bv Per Share	33.99
Ch10y	48.2
Ch1m	14.64
Ch1w	-3.24
Ch1y	170.5
Ch3m	4.47
Ch3y	176.3
Ch5y	146.6
Ch6m	15.31
Change	-2.91%
Change From Open	-1.97
Close	83.95
Days Gap	-0.95
Depreciation Amortization	13,373,575
Dollar Volume	172,882.7
Earnings Date	2026-05-30
EBIT	INR 26.8M
EBITDA	INR 40.2M
EPS	INR 0.45
F Score	1
Fiscal Year End	March
Founded	1,995
Graham Number	18.64511
Graham Upside	-77.13
Income Tax	INR 2.2M
Is Primary Listing	1
Last Earnings Date	2026-02-14
Last Report Date	2025-12-31
Lynch Fair Value	INR 2.27
Lynch Upside	-97.21
Ma150	77.38
Ma150ch	5.34%
Ma20	82.74
Ma20ch	-1.48%
Next Earnings Date	2026-05-30
Open	83.15
Position In Range	22.3
Price Date	2026-05-08
Price EBITDA	INR 26.7
Ptbv Ratio	3.12
Relative Volume	0.37x
Revenue	512,406,000x
Tax By Revenue	0.43x
Tax Rate	27.79%
Tr6m	15.31%
Volume	2,121

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BOM/538965 pay a dividend?

Capital-return profile for this ticker.

Performance

BOM/538965 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BOM/538965?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+66.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+25.5%

Negative means the company is buying back shares.

Technical

BOM/538965 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

50.8

Neutral momentum band

Price vs 200-day MA

+11.6%

50/200-day relationship not available

Beta (5Y)

0.60

Less volatile than the market

Sharpe ratio

2.05

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BOM/538965

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bom/538965 stock rating?

bom/538965 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bom/538965 analysis?

The full report lives at /stocks/bom/538965/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bom/538965?

The latest report frames bom/538965 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bom/538965 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.